v3.26.1
Material accounting policies and use of significant judgements and estimates - Income statement (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure of initial application of standards or interpretations [line items]      
Revenue $ 3,058,109 $ 2,034,261 [1] $ 2,368,085 [1]
Cost of sales 4,142,019 2,910,428 [1] 2,778,222 [1]
Impairment expense, net of reversals (1,049,851) (622,092) [1] (339,568) [1]
Other cost of sales (3,092,168) (2,288,336) [1] (2,438,654) [1]
Gross loss (1,083,910) (876,167) [1] (410,137) [1]
Selling, general and administrative expense (856,458) (890,703) [1] (944,177) [1]
Research and development expense (77,636) (38,350) [1] (157,280) [1]
Other operating income (expense), net   0 0
Other operating income 52,413 59,432 [1] 62,937 [1]
Other operating expense (87,810) (23,818) [1] (58,323) [1]
Foreign exchange gains (losses) on operating activities, net 44,144 (43,705) [1] 37,466 [1]
Operating loss (2,009,257) (1,813,311) [1] (1,469,514) [1]
Finance income 8,996 23,879 [1] 32,329 [1]
Finance expense (385,190) (341,182) [1] (213,242) [1]
Foreign exchange gains (losses) on financial activities, net 50,282 (52,603) [1] 37,236 [1]
Fair value change - Earn-out rights   0 0
Fair value change - Class C Shares   0 0
Fair value changes - Earn-out rights and Class C shares 23,391 129,124 [1] 465,168 [1]
Share of losses in associates (49,145) (4,970) [1] (43,304) [1]
Loss before income taxes (2,360,923) (2,059,063) [1] (1,191,327) [1]
Income tax benefit 3,692 9,166 [1] 9,452 [1]
Net loss $ (2,357,231) (2,049,897) [1] (1,181,875) [1]
As previously reported      
Disclosure of initial application of standards or interpretations [line items]      
Revenue   2,034,261 2,368,085
Cost of sales   2,910,428 2,778,222
Impairment expense, net of reversals   0 0
Other cost of sales   0 0
Gross loss   (876,167) (410,137)
Selling, general and administrative expense   (890,703) (944,177)
Research and development expense   (38,350) (157,280)
Other operating income (expense), net   (8,091) 42,080
Other operating income   0 0
Other operating expense   0 0
Foreign exchange gains (losses) on operating activities, net   0 0
Operating loss   (1,813,311) (1,469,514)
Finance income   23,879 69,565
Finance expense   (393,785) (213,242)
Foreign exchange gains (losses) on financial activities, net   0 0
Fair value change - Earn-out rights   126,624 443,168
Fair value change - Class C Shares   2,500 22,000
Fair value changes - Earn-out rights and Class C shares   0 0
Share of losses in associates   (4,970) (43,304)
Loss before income taxes   (2,059,063) (1,191,327)
Income tax benefit   9,166 9,452
Net loss   (2,049,897) (1,181,875)
Impact of presentation changes      
Disclosure of initial application of standards or interpretations [line items]      
Revenue   0 0
Cost of sales   0 0
Impairment expense, net of reversals   (622,092) (339,568)
Other cost of sales   (2,288,336) (2,438,654)
Gross loss   0 0
Selling, general and administrative expense   0 0
Research and development expense   0 0
Other operating income (expense), net   8,091 (42,080)
Other operating income   59,432 62,937
Other operating expense   (23,818) (58,323)
Foreign exchange gains (losses) on operating activities, net   (43,705) 37,466
Operating loss   0 0
Finance income   0 (37,236)
Finance expense   52,603 0
Foreign exchange gains (losses) on financial activities, net   (52,603) 37,236
Fair value change - Earn-out rights   (126,624) (443,168)
Fair value change - Class C Shares   (2,500) (22,000)
Fair value changes - Earn-out rights and Class C shares   129,124 465,168
Share of losses in associates   0 0
Loss before income taxes   0 0
Income tax benefit   0 0
Net loss   $ 0 $ 0
[1] Certain figures and descriptions were re-presented (see Voluntary re-presentation from previous year in Note 2 - Material accounting policies and use of significant judgements and estimates).